4//SEC Filing
Bornstein Yoseph 4
Accession 0001493152-20-019036
CIK 0000883975other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:58 PM ET
Size
7.2 KB
Accession
0001493152-20-019036
Insider Transaction Report
Form 4
Bornstein Yoseph
Director10% Owner
Transactions
- Sale
Common Stock
2020-10-05$7.74/sh−14,881$115,213→ 272,028 total(indirect: By LSA- LifeScience Accelerator Ltd.) - Sale
Common Stock
2020-10-05$7.74/sh−5,119$39,637→ 266,909 total(indirect: By LSA- LifeScience Accelerator Ltd.)
Footnotes (2)
- [F1]Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 20,000 shares of Issuer common stock on October 5, 2020. Accordingly, Reporting Person beneficially owned 266,909 shares of Issuer common stock following the reported transactions.
- [F2]Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. ("LSA") and of Shizim Ltd. ("Shizim"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities.
Documents
Issuer
Microbot Medical Inc.
CIK 0000883975
Entity typeother
Related Parties
1- filerCIK 0001690100
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:58 PM ET
- Size
- 7.2 KB